Clinical Trials Browser

Phase NA × irinotecan sucrosofate × 1 year × Clear all

NCT07474103 2026-03-16

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Phase NA Recruiting

Gastrointestinal

Rectal Neoplasms

NCT06258642 2025-08-20

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

Phase NA Recruiting

Small Cell Lung Carcinoma